Södertälje, Sweden

Kjell J Mattsson

This inventor holds 1 USPTO granted patent. Top assignee: Astra Lakemedel Aktiebolag. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kjell J Mattsson. Retrieved from https://idiyas.com/inventor/kjell-j-mattsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kjell J Mattsson: Innovator in Pharmaceutical Dosage Forms

Introduction

Kjell J Mattsson is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the delivery of pharmaceutically active substances.

Latest Patents

Kjell J Mattsson holds a patent for a liquid dosage form designed for oral administration of a pharmaceutically active substance. This dosage form is characterized by the inclusion of an encapsulated or embedded pharmaceutically active substance in a pharmaceutically acceptable non-aqueous liquid. This innovation aims to improve the efficacy and convenience of medication delivery.

Career Highlights

Kjell J Mattsson is associated with Astra Lakemedel Aktiebolag, a company known for its commitment to pharmaceutical advancements. His work at Astra has allowed him to contribute to the development of new and effective medication forms.

Collaborations

Throughout his career, Kjell has collaborated with esteemed colleagues such as Alf G Nicklasson and Rolf I Sjoovist. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kjell J Mattsson's contributions to pharmaceutical dosage forms exemplify the importance of innovation in medicine. His patent reflects a commitment to improving patient care through effective drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…